New HIV/AIDS Study Findings Recently Were Reported by Researchers at University of Rochester School of Medicine and Dentistry

2011 APR 13 -- A report, 'A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects,' is newly published data in Vaccine. According to recent research from , "We evaluated replication-defective poxvirus vectors (modified vaccinia Ankara [MVA] and fowlpox [FPV]) in a homologous and heterologous vector prime-boost vaccination regimen containing matching HIV inserts (MVA-HIV and FPV-HIV) given at months 0, 1, 3, 5 and 7 in 150 healthy HIV-negative vaccinia-naive participants. FPV-HIV alone was poorly immunogenic, while the high dose (10(9)pfu/2 ml) of MVA-HIV alone elicited maximal...

Want to see the full article?

• Purchase this article for only $3.00